Skip to main content
. Author manuscript; available in PMC: 2008 Jan 17.
Published in final edited form as: Endocrinology. 2006 Sep 7;147(12):5940–5947. doi: 10.1210/en.2006-0866

Figure 5.

Figure 5

The effects of repeated icv administration (once daily for three days) of POMC-derived peptide on body composition. (A) Total lean and fat mass assessed by DEXA (B) Total liver mass and regional fat depot mass, meso=mesenteric fat, retro= retroperitoneal fat, gonad= gonadal fat, subcut= subcutaneous, (n=6-8 per group, * p<0.05, **p<0.01 vs sham).